^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    tasquinimod (ABR-215050)

    i
    Other names: ABR-215050
    Associations
    News

    Trials

    Company:
    Active Biotech
    Drug class:
    HIF-1 inhibitor, S100A9 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT02159950)
    Phase 2
    Roswell Park Cancer Institute
    Completed
    Last update posted :
    04/27/2023
    Initiation :
    01/01/2015
    Primary completion :
    07/01/2015
    IFNG
    |
    Provenge (sipuleucel-T) • tasquinimod (ABR-215050)
    A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers (NCT01743469)
    Phase 2
    Ipsen
    Completed
    Last update posted :
    01/08/2019
    Initiation :
    12/01/2012
    Primary completion :
    12/01/2014
    Completion :
    04/01/2016
    HER-2
    |
    EGFR positive
    |
    tasquinimod (ABR-215050)